Similar Papers

Paper Title
Journal
Date
Author
Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial
Oleg Aleksandrovich Shukhov ... E.Yu Chelysheva
Clinical oncohematology | VOL. 14
Oleg Aleksandrovich Shukhov, et. al.Oleg Aleksandrovich Shukhov ... E.Yu Chelysheva
01 Jan 2020
Clinical Significance of Deeper Molecular Responses with Four Modalities of Tyrosine Kinase Inhibitors As Frontline Therapy for Chronic Myeloid Leukemia
Lorenzo Falchi ... Jorge E Cortes
Blood | VOL. 120
Lorenzo Falchi, et. al.Lorenzo Falchi ... Jorge E Cortes
16 Nov 2012
Efficacy of Ponatinib after Multiple Lines of Therapy for Chronic Myeloid Leukemia
Mahesh Swaminathan ... Jorge E Cortes
Blood | VOL. 132
Mahesh Swaminathan, et. al.Mahesh Swaminathan ... Jorge E Cortes
29 Nov 2018
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
Timothy Hughes
Nature Clinical Practice Oncology | VOL. 5
Timothy HughesTimothy Hughes
16 Oct 2007
View more papers

More From: Clinical Lymphoma Myeloma and Leukemia

Paper Title
Journal
Date
Author
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis
Moazzam Shahzad ... Muhammad Umair Mushtaq
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Moazzam Shahzad, et. al.Moazzam Shahzad ... Muhammad Umair Mushtaq
01 Jan 2025
Effect of TKI maintenance therapy after allogeneic hematopoietic stem cell transplantation on recurrence of Philadelphia chromosome-positive acute lymphoblastic leukemia p190 and p210 transcripts - a multicentre study
Jiayi Zhen ... Ganlin He
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Jiayi Zhen, et. al.Jiayi Zhen ... Ganlin He
01 Jan 2025
Disease characteristics and treatment outcomes of Myeloma patients under 50 years of age: an analysis of the Balkan Myeloma Study Group
Despina Fotiou ... Efstathios Kastritis
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Despina Fotiou, et. al.Despina Fotiou ... Efstathios Kastritis
01 Jan 2025
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic Leukemia
Elias J Jabbour ... Matthias Stelljes
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Elias J Jabbour, et. al.Elias J Jabbour ... Matthias Stelljes
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.